SCHEMBL29965207

SCHEMBL29965207

CC(C)N1CCCN(c2ccc(Br)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
PKM P14618 1/20 0.59
ESRRB O95718 3/20 0.50
ESRRG P62508 3/20 0.50
KCNH2 Q12809 1/20 0.49
HRH3 Q9Y5N1 1/20 0.43
HDAC4 P56524 1/20 0.43
HTR7 P34969 1/20 0.42
USP2 O75604 1/20 0.41
KMT2A Q03164 1/20 0.41
AKR1C3 P42330 1/20 0.41
F10 P00742 1/20 0.39
FYN P06241 1/20 0.39
IGF1R P08069 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2543118 0.93 KDM4E (0.67) KDM4EALDH1A1MAPTPKMESRRB
SCHEMBL82265 0.84 MAPT (0.61) KDM4EALDH1A1MAPTPKMESRRB
SCHEMBL13904141 0.83 MAPT (0.59) KDM4EALDH1A1MAPTPKMHRH3
SCHEMBL14161817 0.82 KDM4E (0.58) KDM4EALDH1A1MAPTPKMESRRB
SCHEMBL23705658 0.81 KMT2A (0.53) KDM4EALDH1A1MAPTUSP2KMT2A
SCHEMBL20907915 0.80 ALDH1A1 (0.56) KDM4EALDH1A1MAPTPKMESRRB
SCHEMBL10092692 0.79 CHKA (0.60) KDM4EALDH1A1MAPTPKMKCNH2
SCHEMBL22984347 0.79 MAPT (0.54) KDM4EALDH1A1MAPTPKMHRH3
SCHEMBL25160788 0.79 MAPT (0.49) KDM4EALDH1A1MAPTPKMESRRB
SCHEMBL24618822 0.79 MAPT (0.60) KDM4EALDH1A1MAPTPKMESRRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 KDM4E 1986/4885ALDH1A1 1521/4885MAPT 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.